| Application no. and date | 19154482.4 (espacenet) (Federated) (European Patent Register), 20111114 | | Patent/reg. no. and date | DK/EP 3502138, 20220119 | | Publication date | 20190626 | | Priority no. and date | US 41356710 P, 20101115 | | EP pub. no. and date |
EP 3502138 20190626 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | BT/GP/165986 | | Inventor | Heusser, Christoph, Novartis Pharma AG
Lichtstrasse 35
4056 Basel, CH,
Rush, James, Novartis Pharma AG
Lichtstrasse 35
4056 Basel, CH,
Vincent, Karen, Novartis Pharma AG
Lichtstrasse 35
4056 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | C07K 16/28 (2006.01) | | Title | Tavse Fc-varianter af anti-CD40-antistoffer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
